Emerging research suggests that exposure to micro- and nanoplastics may be linked to biological processes involved in Parkinson’s disease, according to a review published in npj Parkinson's Disease. The review examines experimental and mechanistic evidence connecting these tiny plastic particles to the development of the neurological disorder.
Researchers found that microplastics (1 µm to 5 mm) and nanoplastics (<1 µm), which are produced as larger plastic debris breaks down in the environment, can enter the human body through ingestion, inhalation, or skin contact. Once inside, these particles have been detected in blood, liver, and brain tissue at significant concentrations.
The review describes how these plastics can cross biological barriers such as the blood-brain barrier and accumulate in neural tissue. It identifies several molecular mechanisms by which plastics might contribute to neurodegeneration: protein aggregation, mitochondrial dysfunction, neuroinflammation, and disruption of gut-brain signaling.
One mechanism discussed is the acceleration of alpha-synuclein protein clumping—a hallmark of Parkinson’s disease—by nanoplastics acting as scaffolds for aggregation. In patient-derived cell models, nanoplastics increased alpha-synuclein aggregates by about 50% and reduced lysosomal degradation efficiency by around 30%. Oral exposure was shown to damage intestinal barriers and alter gut microbiome composition in animal studies.
Other findings indicate that polystyrene nanoplastics can inhibit cellular energy production pathways, increase oxidative stress, and promote neuronal death. Plastics also impair astrocyte function and can transport heavy metals that disrupt iron balance in the brain.
Parkinson’s disease is recognized as the second most common neurodegenerative disorder worldwide. Its incidence is increasing rapidly—faster than any other neurological condition—and environmental factors are thought to play a major role alongside aging and genetics.
The review concludes that while there is biological plausibility for a link between plastic pollution and Parkinson’s disease based on preclinical evidence, more research is needed. The authors call for large-scale human studies that combine environmental exposure data with long-term clinical follow-up to better understand potential risks.
